Indications and uses
- for the treatment of acne - reduces the number and severity of acne blemishes and allows skin to heal
- for the treatment of acne - reduces the number and severity of acne blemishes and allows skin to heal
- clean the skin thoroughly before applying this product - cover the entire affected area with a thin layer one to three times daily - because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor - if bothersome dryness or peeling occurs, reduce application to once a day or every other day
store in a cool, dark place
Salicylic acid 0.5%
Acne treatment
- for the treatment of acne
- reduces the number and severity of acne blemishes and allows skin to heal
For external use only
Keep away from flames and heat.
skin irritation and dryness is more liekly to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
If swallowed, get medical help or contact a Poison Control Center right away.
- clean the skin thoroughly before applying this product
- cover the entire affected area with a thin layer one to three times daily
- because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
- if bothersome dryness or peeling occurs, reduce application to once a day or every other day
store in a cool, dark place
water, alcohol denat., ascorbic acid, propylene glycol, dipropylene glycol, laureth-23, silybum marianum fruit extract, sodium citrate, ferulic acid
Call 1-800-811-1660 Monday - Friday (9 a.m. - 5 p.m. CST)
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69625-069-01 | SkinCeuticals Silymarin CF Acne Treatment Antioxidant | 30 mL in 1 BOTTLE | SOLUTION | 30 | 3 | |
| 69625-069-01 | SkinCeuticals Silymarin CF Acne Treatment Antioxidant | 1 in 1 CARTON | SOLUTION | 1 | 3 | |
| 69625-069-02 | SkinCeuticals Silymarin CF Acne Treatment Antioxidant | 55 mL in 1 BOTTLE | SOLUTION | 55 | 3 | |
| 69625-069-02 | SkinCeuticals Silymarin CF Acne Treatment Antioxidant | 1 in 1 CARTON | SOLUTION | 1 | 3 | |
| 69625-069-03 | SkinCeuticals Silymarin CF Acne Treatment Antioxidant | 15 mL in 1 BOTTLE | SOLUTION | 15 | 3 | |
| 69625-069-03 | SkinCeuticals Silymarin CF Acne Treatment Antioxidant | 1 in 1 CARTON | SOLUTION | 1 | 3 | |
| 69625-069-04 | SkinCeuticals Silymarin CF Acne Treatment Antioxidant | 10 in 1 CARTON | SOLUTION | 10 | 3 | |
| 69625-069-04 | SkinCeuticals Silymarin CF Acne Treatment Antioxidant | 4 mL in 1 VIAL | SOLUTION | 4 | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69625-069 | 69625-069-01, 69625-069-02, 69625-069-03, 69625-069-04 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SALICYLIC ACID | O414PZ4LPZ | ACTIB |
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | IACT |
| ASCORBIC ACID | PQ6CK8PD0R | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| DIPROPYLENE GLYCOL | E107L85C40 | IACT |
| LAURETH-23 | N72LMW566G | IACT |
| MILK THISTLE | U946SH95EE | IACT |
| SODIUM CITRATE | 1Q73Q2JULR | IACT |
| FERULIC ACID | AVM951ZWST | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SkinCeuticals Silymarin CF Acne Treatment Antioxidant | SALICYLIC ACID | Cosmetique Active Production | fcc3c44b-3090-45b5-91e4-e591c92a08c8 | 2024-06-24 | Warnings | 69625-069-03 69625-069-01 69625-069-04 69625-069-02 69625-069 69625006904 69625006903 69625006901 69625006902 eba37aa1-d9ac-4395-ba35-88d6fbd42d59 fcc3c44b-3090-45b5-91e4-e591c92a08c8 |
Adverse event summaries are temporarily unavailable. Other product information remains available.